Effect of interferon alpha-2a on hormone receptor status in patients with advanced breast cancer

Cancer Investigation

Volumn 17, Issue 3, 1999, Pages 189-194

  Kornek, Gabriela ^a,d   Reiner, Angelika ^b   Sagaster, Peter ^a   Stierer, Michael ^c   Mayer, Astrid ^a   Ludwig, Heinz ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b DANUBE HOSPITAL   (Austria)

^c HANUSCH HOSPITAL   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Advanced breast cancer; Hormone receptor status; Interferon alpha 2a

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FLU LIKE SYNDROME; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SKIN METASTASIS; TISSUE DISTRIBUTION;

EID: 0032993907     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909021420     Document Type: Article

References (19)

1. Rose C, Thorpe SM, Anderson KW, et al: Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1:16-23, 1985.
2. Allegra JC, Lippman ME, Thompson EB, et al: Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 16:323-331, 1980.
3. Allegra JC, Barlock A, Huff KK, et al: Changes in multiple or sequential estrogen receptor determinations in breast cancer. Cancer 45:792-794, 1980.
4. Sherwin SA, Mayer D, Ochs JJ, et al: Recombinant leucocyte interferon in advanced breast cancer. Ann Intern Med 99: 598-602, 1983.
5. Borden EC, Holland JF, Dao TL, et al: Leucocyte derived interferon alpha in human breast carcinoma. Ann Intern Med 27:1-6, 1982.
6. Nethersell A, Smedley H, Katrak M, et al: Recombinant interferon in advanced breast cancer. Br J Cancer 49:615-20, 1984.
7. Bezwoda WR, Meyer K: Effect of alpha-interferon, 17 beta-estradiol and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells. Cancer Res 50:5387-5391, 1990.
8. Seymour L, Bezwoda WR: Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators. Br J Cancer 68:353-356, 1993.
9. Hayward JL, Carbone PP, Heuson JC, et al: Assessment of response to therapy in advanced breast cancer. Cancer 39:1289-1294, 1977.
10. Andersen J, Poulsen HS: Relationship between estrogen receptor status in the primary tumor and its regional and distant metastases. An immunohistochemical study in human breast cancer. Acta Oncol 27:761-765, 1988.
11. Van den Berg HW, Leakey WJ, Lynch M, et al: Recombinant human interferon alpha increases estrogen, receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen. Br J Cancer 55:255-257, 1987.
12. Sica G, Natoli V, Stella C, et al: Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Cancer 60:2419-2423, 1987.
13. Pouillart P, Palangie T, Jouve M, et al: Administration of fibre-blast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur J Cancer Clin Oncol 18:929-935, 1982.
14. Macheledt JE, Buzdar AU, Hortobagyi GN, et al: Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer. Breast Cancer Res Treatm 18:165-170, 1991.
15. Marth CH, Mayer I, Boch G, et al: Effects of human interferon alpha-2 and gamma on proliferation, estrogen receptor content, and sensitivity to anti-estrogens of cultured breast cancer cells. In: The Interferon System, edited by F Dianzahl, GH, New York, Raven Press, 1985, pp 367-371.
16. Kauppila A, Centell K, Janne O, et al: Serum sex steroid and peptide hormone concentrations, and endometrial estrogen and progestin receptor levels during administration of human leukocyte interferon. Int J Cancer 29:291-294, 1982.
17. Porzsolt F, Otto AM, Trauschel B, et al: Rationale for combining tamoxifen and interferon in the treatment of advanced breast cancer. J Cancer Res Clin Oncol 115:465-469, 1989.
18. Crawford DJ, Cowan S, Fitch R, et al: Stability of estrogen receptor status in sequential biopsies from patients with breast cancer. Br J Cancer 56:137-144, 1987.
19. Nomura Y, Tashiro H, Shinozuka K: Changes of steroid hormone content by chemotherapy and/or endocrine therapy in advanced breast cancer. Cancer 55:546-552, 1985.